Subcutaneous ICD Overview

The S-ICD avoids the vasculature entirely. The generator sits in a left lateral or sub-axillary pocket, and a single tunneled lead runs to a left parasternal position. Sensing and shocking happen through three available vectors between the lead’s distal sense electrode, proximal sense electrode, and the generator can.

How the system works

• Pulse generator houses the battery, capacitor, sensing circuit, and processor. Larger than a transvenous ICD because of the longer shock vector requirement. Current EMBLEM MRI device is approximately 60 cm³ and 130 g.
• Lead. A single tunneled subcutaneous lead with:
  • Distal sense electrode at the superior parasternal border
  • Proximal sense electrode at the xiphoid
  • 8-cm shock coil between the two electrodes
• Three sensing vectors:
  • Primary: proximal electrode → can
  • Secondary: distal electrode → can
  • Alternate: distal electrode → proximal electrode
• Adaptive filtering.
  • SMART Pass filters high-frequency noise and reduces T-wave amplitude relative to R-wave — the central defense against T-wave oversensing.
  • SMART Charge delays capacitor charging when the device suspects oversensing, giving the rhythm a chance to self-terminate or for the algorithm to reassess.
• Shock energy. Up to 80 J device; default programmed first shock is 65 J. Subsequent shocks at maximum output.
• Post-shock pacing. Transthoracic pacing at 50 bpm for up to 30 seconds, bridging asystolic pauses. Not chronic pacing.

Comparison: S-ICD vs EV-ICD vs Transvenous ICD

Types and variants

• Current US platform: Boston Scientific EMBLEM MRI S-ICD with the EMBLEM generator. MRI-conditional under specific protocols.
• Modular EMBLEM + EMPOWER pairing. Boston Scientific’s EMPOWER modular leadless pacemaker is designed to communicate with the EMBLEM S-ICD, adding ATP and chronic bradycardia pacing without adding a transvenous lead. The pairing is still maturing on the US market.

Indications and candidate selection

Strong S-ICD candidates:

• Young patients with inherited arrhythmia syndromes (Long QT, Brugada, HCM, CPVT) and decades of generator changes ahead — keeping the venous system pristine matters.
• Dialysis patients where preserving upper-extremity venous access is essential.
• Patients with prior CIED infection or endocarditis who must not have hardware in the vasculature.
• Patients with congenital heart disease and unusable transvenous access (single-ventricle physiology, Fontan circulation, surgically interrupted IVC).
• Patients with prior multiple lead failures opting out of transvenous pursuit.
• Pediatric and adolescent patients for cosmetic and growth considerations.

Not ideal:

• Patients who need or are likely to need chronic bradycardia pacing.
• Patients with monomorphic VT terminable by ATP — painless therapy preferred.
• HFrEF patients likely to need CRT in the near term.
• Patients who fail S-ICD screening on all three vectors in either posture.
• Severe obesity where the subcutaneous depth compromises sensing or shock delivery.
• Patients with morphology unsuitable for screening (very low R-wave amplitude, pronounced T-waves).

Screening EKG — the gatekeeper

Mandatory before implant. The patient is studied in both supine and standing positions with a templated three-vector recording.

• Recording method. Surface ECG electrodes positioned to mimic the S-ICD sensing vectors (right parasternal, left parasternal, can position approximation). Recordings are overlaid against an acceptable R/T amplitude ratio template provided by Boston Scientific.
• Requirement. At least one vector must pass in both supine and standing positions. Two is comfortable. Failure on all three vectors in either position disqualifies the patient.
• Postural sensitivity. T-wave morphology shifts with position, particularly in patients with structural heart disease or ECG abnormalities. Repeat screening in both postures is non-negotiable.
• Exercise screening. Optional in selected patients (athletes, patients with exercise-induced ECG changes). Treadmill or step test with vector recording during recovery.
• Failure scenarios. Hypertrophic cardiomyopathy with prominent T-wave inversion, athletic ECG patterns, dextrocardia, severe LVH, and selected channelopathies are the most common reasons for failure. Patients who fail screening should be considered for TV-ICD or EV-ICD.

Key programming considerations

• Conditional zone (with discrimination on):
  • Typically 200–230 bpm
  • Morphology-based discrimination engaged
  • Used to suppress shocks for SVT mimicking VT
• Shock zone (discrimination off):
  • Typically ≥230–250 bpm
  • True VF threshold; shock priority, no second-guessing
• Vector selection. Best vector for R/T discrimination as identified at implant; reassess at every clinic visit, particularly with weight change or position drift.
• SMART Pass. Leave enabled unless an investigation specifically identifies it as problematic. SMART Pass disables itself automatically if R-wave amplitude drops below a threshold; this should trigger workup.
• SMART Charge. Default-enabled delay to charging gives self-terminating rhythms a chance to stop.
• Post-shock pacing. 50 bpm transthoracic for 30 seconds. Confirm capture at implant; capture in chronic phase may not be retestable.
• MRI mode. Enable per manufacturer protocol when scanning is required.

Implant technique

Anesthesia and prep

• General anesthesia for routine implants (some centers do deep sedation).
• Patient supine, left arm abducted, right arm at side.
• Chest, axilla, and abdomen prepped and draped.
• Antibiotics per pocket-infection prophylaxis.
• Two-incision technique is now standard for most operators.

Generator pocket — intermuscular

• Left lateral or sub-axillary, between serratus anterior and latissimus dorsi (intermuscular plane).
• Position at the level of the 5th–6th intercostal space, mid-axillary line.
• Intermuscular plane is preferred over subcutaneous for:
  • Lower migration risk
  • Better cosmesis (less visible bulge)
  • More secure pocket
• Pocket dissection with electrocautery; careful hemostasis.

Lead tunneling — two-incision technique

• Xiphoid incision. Small (~2 cm) incision just left of the xiphoid.
• Tunneling. A dedicated tunneling tool advanced subcutaneously from the xiphoid incision superiorly along the left parasternal border, to the level of the superior sternal angle.
• The tool stays superficial — anterior to the rib cage, posterior to the dermis. No third incision is required with current technique.
• Lead is back-loaded through the tunnel via the tunneling tool, leaving the distal sense electrode at the superior parasternal position.
• Anchor at xiphoid. A suture sleeve anchors the lead to the deep fascia at the xiphoid.
• Final position. Lead runs from xiphoid anchor, up the left parasternal line, with the 8-cm shock coil bridging the two sense electrodes.

Generator-lead connection

• Tunnel from the xiphoid incision laterally to the generator pocket along the latissimus.
• Lead connector inserted into the generator; setscrews tightened; pin connection confirmed.

Defibrillation testing

DFT is strongly recommended at S-ICD implant — more important than for modern TV-ICD because of the higher shock energy requirements and longer learning curve with extravascular sensing.

• VF is induced (typically with a 50 Hz burst).
• Programmed first shock (65 J) should terminate VF with a safety margin (≥15 J below max output).
• If first shock fails: vector or position revision, then proceed to max output.
• Document successful conversion in the implant note.

Pre-implant screening confirmation

• Repeat the vector recording after lead positioning is final, confirming the implanted lead reproduces the pre-screening vector choice.
• Small post-implant position shifts can change the best vector — document the post-implant vector and use it for initial programming.

Closure

• Pocket closed in layers; deep absorbable sutures and skin closure of choice.
• Xiphoid incision closed in layers.
• Chest X-ray to document final lead position and rule out pneumothorax (rare with subcutaneous tunneling but possible).

What to know in the lab

• Patient body habitus matters. Thin patients with prominent T-waves may have marginal screening; very large patients may have difficult sensing.
• Pocket bleeding. Intermuscular pocket bleeding is harder to control than subcutaneous. Methodical hemostasis at each layer.
• Lead position. Final coil position should span the cardiac silhouette in PA fluoroscopy. Lateral fluoro confirms parasternal subcutaneous (not substernal — that’s EV-ICD).
• DFT failure. Reposition lead more medially or repeat with shock vector adjustment. Vector reversal (cathode/anode polarity) can rescue marginal cases.
• Single-incision technique. Older alternative; now reserved for selected anatomy. Two-incision is the modern default.

Common issues and troubleshooting

Inappropriate shocks

• T-wave oversensing — switch sensing vector first; confirm SMART Pass enabled; re-evaluate during exercise (oversensing often surfaces only with exertion).
• SVT in the conditional zone — extend detection interval; review morphology template stability.
• Skeletal muscle artifact — typically exercise-related; vector reselection.
• Lead migration — fluoroscopy; if shifted significantly, consider surgical revision.

Sensing issues

• R-wave amplitude drop over serial visits — trend it; fluoroscopic check; consider revision if <2 mV chronic.
• Vector instability — if best vector keeps changing visit-to-visit, weight change or lead position drift may be the cause.
• SMART Pass auto-disable — workup R-wave amplitude; if persistently low, vector revision or system review.

Pocket issues

• Pre-pectoral migration — uncommon with intermuscular technique but can happen; pocket revision.
• Discomfort — typical first 4–6 weeks; persistent pain warrants imaging.
• Infection — standard CIED infection management; extraction may be required.

Anticipating the need for ATP or pacing later

• New monomorphic VT detected on event log that would have terminated with ATP — counsel patient; consider EMBLEM + EMPOWER pairing or system swap to TV-ICD.
• Development of bradycardia indication — leadless pacemaker companion (EMPOWER pairing) or system swap.

Generator change and extraction

• Generator longevity: 5–7 years typical.
• Generator change: standard procedure — pocket reopening, swap, reconnect.
• Lead extraction: rarely needed; if required (infection, dysfunction), the subcutaneous tunnel allows relatively straightforward removal compared to transvenous extraction.
• System upgrade: planned conversion to TV-ICD when ATP or pacing becomes necessary. The S-ICD is removed and the new transvenous system is implanted.

Manufacturer reference

• Boston Scientific EMBLEM S-ICD System